Back
ESC2025 Premium Access

The role of TAK1 inhibition in doxorubicin-induced cardiotoxicity: an in vitro study

Session: Cardio-oncology and therapy
Topic: Cancer Biology and Treatment
Speaker: Associate Professor B. Polegato (Botucatu, BR)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Bertha Polegato

Faculty of Medicine of Botucatu, UNESP, Botucatu (Brazil)
0 follower

3 more presentations in this session

NLRP3/IL-1 pathway was reduced by semaglutide and dapagliflozin in association therapy under exposure to anthracyclines in hyperglycemic conditions

Speaker: Doctor N. Maurea (Naples, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Age- and sex-specific association between clonal hematopoiesis of indeterminate potential and pulmonary hypertension

Speaker: Doctor G. Sun (Guangzhou, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Variability in echocardiographic surveillance for cardiotoxicity in HER2+ versus HER2- breast cancer: a SEER-medicare analysis

Speaker: Associate Professor J. Strom (Boston, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardio-oncology and therapy

Speakers: Associate Professor B. Polegato, Doctor N. Maurea, Doctor G. Sun, Associate Professor J. Strom
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources